Last reviewed · How we verify

Therapeutic hepatitis B vaccine

Vaxine Pty Ltd · Phase 1 active Biologic

Therapeutic hepatitis B vaccine is a Biologic drug developed by Vaxine Pty Ltd. It is currently in Phase 1 development. Also known as: Hepadvax(TM).

At a glance

Generic nameTherapeutic hepatitis B vaccine
Also known asHepadvax(TM)
SponsorVaxine Pty Ltd
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Therapeutic hepatitis B vaccine

What is Therapeutic hepatitis B vaccine?

Therapeutic hepatitis B vaccine is a Biologic drug developed by Vaxine Pty Ltd.

Who makes Therapeutic hepatitis B vaccine?

Therapeutic hepatitis B vaccine is developed by Vaxine Pty Ltd (see full Vaxine Pty Ltd pipeline at /company/vaxine-pty-ltd).

Is Therapeutic hepatitis B vaccine also known as anything else?

Therapeutic hepatitis B vaccine is also known as Hepadvax(TM).

What development phase is Therapeutic hepatitis B vaccine in?

Therapeutic hepatitis B vaccine is in Phase 1.

Related